SEC Company Response from CareCloud, Inc. (CCLD, CCLDO) (CIK 0001582982) (CCLD) — Jul 21, 2014
CareCloud, Inc. (CCLD, CCLDO) (CIK 0001582982)
Date: July 21, 2014 · CIK: 0001582982 · Accession: 0001144204-14-043963
AI Filing Summary & Sentiment
File numbers found in text: 333-192989
Letter
Park Avenue, Suite 1500
New York, NY 10017
Tel 212.878.7900 Fax 212.692.0940
www.foxrothschild.com
Alison Newman
Direct Dial: 212-878-7997
Email Address: ANewman@Foxrothschild.com
July 21, 2014
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Attention: Mark P. Shuman
Ivan Griswold
Laura Veator
Stephen Krikorian
Re: Medical Transcription Billing, Corp.
Amendment No. 8 to Registration Statement on Form S-1
Filed on July 21, 2014
File No. 333-192989
Ladies and Gentlemen:
On behalf of our client, Medical Transcription Billing, Corp. (“MTBC” or the “Company”), we are responding to oral comments of the staff of the Securities and Exchange Commission provided to us today relating to the above referenced Amendment No. 8 to Registration Statement on Form S-1 (the “Registration Statement”).
Please be advised that we have discussed with the Company, the underwriters and counsel for the underwriters the disclosure on pages 1, 55, 61 and 99 of the Registration Statement regarding the circumstances leading up to the reduction in the offering price on July 10, 2014. The Company and the underwriters believe that such disclosure adequately describes the circumstances regarding the reduction in the offering price in all material respects and that there are no additional material facts specific to the Company that the Company or the underwriters are aware of that should be disclosed in the Registration Statement in order to make those statements not misleading.
Sincerely,
/s/ Alison Newman
Show Raw Text
CORRESP
1
filename1.htm
100
Park Avenue, Suite 1500
New York,
NY 10017
Tel 212.878.7900
Fax 212.692.0940
www.foxrothschild.com
Alison Newman
Direct Dial: 212-878-7997
Email Address: ANewman@Foxrothschild.com
July 21, 2014
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Attention: Mark P. Shuman
Ivan Griswold
Laura Veator
Stephen Krikorian
Re: Medical Transcription Billing, Corp.
Amendment No. 8 to Registration Statement on Form S-1
Filed on July 21, 2014
File No. 333-192989
Ladies and Gentlemen:
On behalf of our
client, Medical Transcription Billing, Corp. (“MTBC” or the “Company”), we are responding
to oral comments of the staff of the Securities and Exchange Commission provided to us today relating to the above referenced Amendment
No. 8 to Registration Statement on Form S-1 (the “Registration Statement”).
Please be advised that we have discussed with the Company, the underwriters and counsel for the underwriters
the disclosure on pages 1, 55, 61 and 99 of the Registration Statement regarding the circumstances leading up to the reduction
in the offering price on July 10, 2014. The Company and the underwriters believe that such disclosure adequately describes the
circumstances regarding the reduction in the offering price in all material respects and that there are no additional material
facts specific to the Company that the Company or the underwriters are aware of that should be disclosed in the Registration Statement
in order to make those statements not misleading.
Sincerely,
/s/ Alison Newman
cc: Mahmud Haq, Medical Transcription Billing, Corp.
Bill Korn, Medical Transcription Billing, Corp.
Stephen Snyder, Medical Transcription Billing, Corp.
Mitchell Nussbaum, Loeb & Loeb LLP